AVALIDE - 0087-2875-31 - (IRBESARTAN AND HYDROCHLOROTHIAZIDE)

Alphabetical Index


Drug Information of AVALIDE

Product NDC: 0087-2875
Proprietary Name: AVALIDE
Non Proprietary Name: IRBESARTAN AND HYDROCHLOROTHIAZIDE
Active Ingredient(s): 12.5; 150    mg/1; mg/1 & nbsp;   IRBESARTAN AND HYDROCHLOROTHIAZIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of AVALIDE

Product NDC: 0087-2875
Labeler Name: Bristol-Myers Squibb Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020758
Marketing Category: NDA
Start Marketing Date: 20110225

Package Information of AVALIDE

Package NDC: 0087-2875-31
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0087-2875-31)

NDC Information of AVALIDE

NDC Code 0087-2875-31
Proprietary Name AVALIDE
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (0087-2875-31)
Product NDC 0087-2875
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name IRBESARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110225
Marketing Category Name NDA
Labeler Name Bristol-Myers Squibb Company
Substance Name HYDROCHLOROTHIAZIDE; IRBESARTAN
Strength Number 12.5; 150
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of AVALIDE


General Information